Amalgamated Bank lessened its stake in National HealthCare Co. (NYSE:NHC – Free Report) by 12.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,590 shares of the company’s stock after selling 507 shares during the period. Amalgamated Bank’s holdings in National HealthCare were worth $452,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of NHC. Robeco Institutional Asset Management B.V. lifted its stake in shares of National HealthCare by 223.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 20,899 shares of the company’s stock valued at $2,628,000 after purchasing an additional 14,445 shares during the period. Nisa Investment Advisors LLC increased its holdings in National HealthCare by 5.3% in the third quarter. Nisa Investment Advisors LLC now owns 4,091 shares of the company’s stock valued at $517,000 after buying an additional 206 shares in the last quarter. DekaBank Deutsche Girozentrale raised its position in shares of National HealthCare by 1,277.1% in the third quarter. DekaBank Deutsche Girozentrale now owns 10,411 shares of the company’s stock worth $1,255,000 after acquiring an additional 9,655 shares during the period. Ballentine Partners LLC purchased a new stake in shares of National HealthCare during the 3rd quarter worth about $223,000. Finally, Copeland Capital Management LLC acquired a new stake in shares of National HealthCare during the 3rd quarter valued at about $62,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.
National HealthCare Price Performance
Shares of NYSE:NHC opened at $125.86 on Friday. The company’s 50 day simple moving average is $123.50. National HealthCare Co. has a 1 year low of $73.96 and a 1 year high of $138.49. The stock has a market cap of $1.94 billion, a price-to-earnings ratio of 15.77 and a beta of 0.41. The company has a quick ratio of 1.77, a current ratio of 1.80 and a debt-to-equity ratio of 0.14.
National HealthCare Announces Dividend
Analysts Set New Price Targets
Separately, StockNews.com raised National HealthCare from a “buy” rating to a “strong-buy” rating in a report on Saturday.
Get Our Latest Research Report on NHC
Insider Transactions at National HealthCare
In other National HealthCare news, SVP Brian F. Kidd sold 2,000 shares of National HealthCare stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.01, for a total transaction of $260,020.00. Following the sale, the senior vice president now owns 21,747 shares of the company’s stock, valued at $2,827,327.47. The trade was a 8.42 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 13.75% of the company’s stock.
About National HealthCare
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
See Also
- Five stocks we like better than National HealthCare
- EV Stocks and How to Profit from Them
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Canada Bond Market Holiday: How to Invest and Trade
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Want to Profit on the Downtrend? Downtrends, Explained.
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Co. (NYSE:NHC – Free Report).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.